Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nahel Elias, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Nahel Elias and Meghan Sise.
Nahel Elias
Connection Strength
2.082
Meghan Sise
  1. Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation. Artif Organs. 2019 Sep; 43(9):913-920.
    View in: PubMed
    Score: 0.817
  2. Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus. Transpl Int. 2021 12; 34(12):2562-2569.
    View in: PubMed
    Score: 0.242
  3. Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant. 2021 12; 35(12):e14466.
    View in: PubMed
    Score: 0.241
  4. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. J Am Soc Nephrol. 2020 11; 31(11):2678-2687.
    View in: PubMed
    Score: 0.223
  5. Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation. Kidney Int Rep. 2020 Apr; 5(4):459-467.
    View in: PubMed
    Score: 0.213
  6. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodial Int. 2018 04; 22 Suppl 1:S71-S80.
    View in: PubMed
    Score: 0.189
  7. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant. 2022 Feb; 22(2):599-609.
    View in: PubMed
    Score: 0.060
  8. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. Am J Transplant. 2020 06; 20(6):1619-1628.
    View in: PubMed
    Score: 0.054
  9. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.